Log in

Newron Pharmaceuticals Stock Forecast, Price & News

0.00 (0.00 %)
(As of 09/18/2020 12:00 AM ET)
Today's Range
Now: $2.55
50-Day Range
MA: $2.34
52-Week Range
Now: $2.55
Average Volume980 shs
Market Capitalization$45.52 million
P/E RatioN/A
Dividend YieldN/A
Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development, manufacture, and distribution of therapies for the treatment of central and peripheral nervous system in Italy and internationally. The company offers Xadago (safinamide) for the treatment of Parkinson's disease. Its pipeline of products include Sarizotan for patients with Rett syndrome; Evenamide, a first add-on therapy for the treatment of patients with positive symptoms of schizophrenia; and Ralfinamide for patients with specific rare pain indications. Newron Pharmaceuticals S.p.A. has a collaboration agreement with Meiji Seika Pharma Co., Ltd. for the development and commercialization of safinamide in Japan and Asian territories. The company was founded in 1998 and is headquartered in Bresso, Italy.
Read More
Newron Pharmaceuticals logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.42 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations



Sales & Book Value

Annual Sales$7.88 million
Book Value$2.31 per share



Market Cap$45.52 million
Next Earnings DateN/A
OptionableNot Optionable
0.00 (0.00 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NWPHF News and Ratings via Email

Sign-up to receive the latest news and ratings for NWPHF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Newron Pharmaceuticals (OTCMKTS:NWPHF) Frequently Asked Questions

How has Newron Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)?

Newron Pharmaceuticals' stock was trading at $7.50 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, NWPHF shares have decreased by 66.0% and is now trading at $2.55.
View which stocks have been most impacted by COVID-19

Are investors shorting Newron Pharmaceuticals?

Newron Pharmaceuticals saw a drop in short interest in the month of August. As of August 31st, there was short interest totaling 100 shares, a drop of 90.0% from the August 15th total of 1,000 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is presently 1.0 days.
View Newron Pharmaceuticals' Short Interest

Who are some of Newron Pharmaceuticals' key competitors?

Who are Newron Pharmaceuticals' key executives?

Newron Pharmaceuticals' management team includes the following people:
  • Mr. Stefan Weber, CEO & Exec. Director (Age 54)
  • Mr. Roberto Galli, VP of Fin.
  • Mr. Marco Caremi, Exec. VP of Bus. Devel. (Age 62)
  • Dr. Ravi Anand, Chief Medical Officer (Age 62)
  • Mr. Dennis Dionne, VP of Commercial Affairs (Age 69)

What is Newron Pharmaceuticals' stock symbol?

Newron Pharmaceuticals trades on the OTCMKTS under the ticker symbol "NWPHF."

How do I buy shares of Newron Pharmaceuticals?

Shares of NWPHF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Newron Pharmaceuticals' stock price today?

One share of NWPHF stock can currently be purchased for approximately $2.55.

How big of a company is Newron Pharmaceuticals?

Newron Pharmaceuticals has a market capitalization of $45.52 million and generates $7.88 million in revenue each year. The company earns $-22,630,000.00 in net income (profit) each year or ($1.27) on an earnings per share basis. Newron Pharmaceuticals employs 24 workers across the globe.

What is Newron Pharmaceuticals' official website?

The official website for Newron Pharmaceuticals is www.newron.com.

How can I contact Newron Pharmaceuticals?

Newron Pharmaceuticals' mailing address is via Antonio Meucci 3 Milan, Bresso L6, 20091. The company can be reached via phone at 39026103461 or via email at [email protected]

This page was last updated on 9/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.